Y mabs Therapeutics inc (YMAB) - News Archive

Y-mAbs Therapeutics, Inc. (Nasdaq: YMAB), a biopharmaceutical company dedicated to pioneering advancements in cancer treatment through radioimmunotherapy and antibody-based products, recently presented a trial in progre...

Y-mAbs Therapeutics, a pioneering biopharmaceutical company dedicated to advancing novel radioimmunotherapy and antibody-based therapeutic products for cancer treatment, has recently unveiled groundbreaking preclinical...

Y-mAbs Announces Promising Phase 2 Data for Naxitamab in the Treatment of High-Risk NeuroblastomaNEW YORK, June 01, 2024 - Y-mAbs Therapeutics, Inc. (Nasdaq: YMAB), a leading biopharmaceutical company specializing in th...